ASKB589 in Combination With CAPOX and PD-1 Inhibitor in Patients With Advanced or Metastatic GC/GEJ Adenocarcinoma
Clinical trial NCT06206733 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06206733
- Sponsor
- AskGene Pharma, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-25
- Primary completion
- 2026-12-30
- Enrollment
- 780
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.